CIK 0001790340
- Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- 4 Open-market buy Director bought 4,750 shares at $24.45 ($116,114)
- 4 Open-market buy Director bought 6,099 shares at an average $21.50 ($131,114)
- 4 Open-market buy PRESIDENT AND CEO bought 2,083 shares at $22.87 ($47,632)
- 3/A Insider 3/A
- 4 Open-market buy Former 10% Owner bought 550,000 shares at $15.00 ($8,250,000)
- 4 Open-market buy Director bought 291,667 shares at $15.00 ($4,375,005)
- 4 Open-market buy President and CEO bought 2,098 shares at $15.00 ($31,470)
- 4 Open-market buy Director bought 7,000 shares at $15.00 ($105,000)
- 4 Open-market buy Chief Scientific Officer bought 1,353 shares at $15.00 ($20,295)
- 4 Open-market buy Director bought 325,000 shares at $15.00 ($4,875,000)
- 4 Open-market buy General Counsel and Secretary bought 1,402 shares at $15.00 ($21,030)
- 4 Open-market buy Director bought 3,500 shares at $15.00 ($52,500)
- 4 Open-market buy Chief Medical Officer bought 667 shares at $15.00 ($10,005)
- 4 Open-market buy CFO, Treasurer bought 4,175 shares at $15.00 ($62,625)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 8 of 9 · 166 filings